UCB, Inc. et al v. Cipla Limited et al
| UCB, Inc., UCB Biopharma SRL, Hananja EHF and University of Iceland |
| Cipla Limited and Cipla USA Inc. |
| 1:2021cv01229 |
| August 26, 2021 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on October 20, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Reset Hearings: The Scheduling Conference is rescheduled per request of counsel for 11/17/2021 at 12:00 PM before Judge Colm F. Connolly. (nmf) |
| Filing 16 ANSWER to #12 Answer to Complaint, Counterclaim - by Hananja EHF, UCB Biopharma SRL, UCB, Inc., University of Iceland.(Dellinger, Megan) |
| Pro Hac Vice Attorneys Anil H. Patel, Peter L. Giunta, Jenna Bruce, and Harold M. Storey for Cipla Limited and Cipla USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
Filing 15
Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 10/28/2021 at 08:00 AM before Judge Colm F. Connolly. Counsel for Plaintiffs shall coordinate the call and email the dial-in information to chambers. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 9/23/2021. (nmf)
|
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Anil H. Patel, Attorney Harold Storey, Attorney Peter Giunta and Attorney Jenna Bruce - filed by Cipla Limited, Cipla USA Inc.. (Dorsney, Kenneth) |
| Filing 13 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cipla Limited., Corporate Parent Cipla (EU Limited), Corporate Parent InvaGen Pharmaceuticals, Inc., for Cipla USA Inc. filed by Cipla Limited, Cipla USA Inc.. (Dorsney, Kenneth) |
| Filing 12 ANSWER to #1 Complaint, , COUNTERCLAIM against All Plaintiffs by Cipla Limited, Cipla USA Inc..(Dorsney, Kenneth) |
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Anil H. Patel, Attorney Harold Storey, Attorney Peter Giunta and Attorney Jenna Bruce filed by Cipla Limited, Cipla USA Inc. Signed by Judge Colm F. Connolly on 9/21/2021. (kmd)
|
| Pro Hac Vice Attorneys Alexa R. Hansen, Melissa Keech for Hananja EHF, UCB Biopharma SRL, UCB, Inc., University of Iceland added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Pro Hac Vice Attorney David S. Denuyl and George F. Pappas for Hananja EHF, UCB Biopharma SRL, UCB, Inc. and University of Iceland added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Filing 11 AFFIDAVIT of Service for Summons, Complaint and related papers served on Cipla Limited on September 1, 2021, filed by Hananja EHF, UCB Biopharma SRL, UCB, Inc., University of Iceland. (Dellinger, Megan) |
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Melissa Keech, Alexa Hansen and David Denuyl filed by Hananja EHF, UCB, Inc., UCB Biopharma SRL, University of Iceland. Signed by Judge Colm F. Connolly on 9/1/2021. (nmf)
|
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Filing 10 SUMMONS Returned Executed by UCB, Inc., UCB Biopharma SRL, Hananja EHF, University of Iceland. Cipla USA Inc. served on 8/31/2021, answer due 9/21/2021. (Blumenfeld, Jack) |
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney George F. Pappas, Melissa Keech, Alexa Hansen and David Denuyl - filed by Hananja EHF, UCB Biopharma SRL, UCB, Inc., University of Iceland. (Dellinger, Megan) |
| Filing 8 Summons Issued with Magistrate Consent Notice attached as to Cipla Limited on 8/27/2021; Cipla USA Inc. on 8/27/2021. (Attachments: #1 Summons Issued)(myr) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by University of Iceland. (myr) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Hananja EHF. (myr) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate UCB SA, Other Affiliate UCB, Inc., Other Affiliate UCB Pharma SA, Other Affiliate UCB Manufacturing, Inc. for UCB Biopharma SRL; Other Affiliate UCB SA, Other Affiliate UCB Holdings, Inc. for UCB, Inc. filed by UCB Biopharma SRL, UCB, Inc.. (myr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,217,033 B2 ;8,809,322 B2 ;9,289,432 B2 ;9,687,495 B2. (myr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 16,2021. Date of Expiration of Patent: January 18,2028 (for all).Thirty Month Stay Deadline: 1/16/2024. (myr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Limited, Cipla USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3687131.) - filed by UCB, Inc., UCB Biopharma SRL, Hananja EHF, University of Iceland. (Attachments: #1 Certificate of Compliance A-D, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
